The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Checkpoint Therapeutics Inc shares valued at $60,964 were sold by Oliviero James F III on Apr 02 ’25. At $4.04 per share, Oliviero James F III sold 15,090 shares. The insider’s holdings dropped to 3,759,929 shares worth approximately $15.68 million following the completion of this transaction.
Also, GRAY WILLIAM GARRETT sold 12,322 shares, netting a total of over 49,904 in proceeds. Following the sale of shares at $4.05 each, the insider now holds 1,446,322 shares.
Before that, Oliviero James F III had sold 10,331 shares from its account. In a trade valued at $32,543, the CEO, President and Director traded Checkpoint Therapeutics Inc shares for $3.15 each. Upon closing the transaction, the insider’s holdings decreased to 10,331 shares, worth approximately $15.74 million.
As published in their initiating research note from D. Boral Capital on January 13, 2025, Checkpoint Therapeutics Inc [CKPT] has been a Buy and the price target has been revised to $9. As of June 09, 2021, B. Riley Securities has initiated its “Buy” rating for CKPT. Earlier on January 20, 2021, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for CKPT stock.
Analyzing CKPT Stock Performance
During the last five days, there has been a surge of approximately 0.48%. Over the course of the year, Checkpoint Therapeutics Inc shares have jumped approximately 30.31%. Shares of the company reached a 52-week high of $4.20 on 05/22/25 and a 52-week low of $2.37 on 03/07/25.
Support And Resistance Levels for Checkpoint Therapeutics Inc (CKPT)
According to the 24-hour chart, there is a support level at 4.15, which, if violated, would cause prices to drop to 4.14. In the upper region, resistance lies at 4.19. The next price resistance is at 4.22. RSI (Relative Strength Index) is 69.05 on the 14-day chart, showing neutral technical sentiment.
